E. Böhni
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
-
- Chemical Synthesis and Analysis 6
- Cancer therapeutics and mechanisms 3
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Co-authors
- W. Lergier (6 shared papers)R. O. Studer (6 shared papers)K. Vogler (6 shared papers)P. Lanz (6 shared papers)J. Rieder (1 shared paper)László Havas (1 shared paper)A. Studer (4 shared papers)Rudolf Then (1 shared paper)
- Journals
- Helvetica Chimica Acta (7 papers)Chemotherapy (4 papers)Cellular and Molecular Life Sciences (2 papers)European Respiratory Journal (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- SwitzerlandUnited States
In The Last Decade
E. Böhni
23 papers receiving 252 citations
Peers
Comparison fields: 5 of 72
- Molecular Medicine 50
- Pharmacology 85
- Microbiology 24
- Epidemiology 77
- Organic Chemistry 61
Countries citing papers authored by E. Böhni
This map shows the geographic impact of E. Böhni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Böhni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Böhni more than expected).
Fields of papers citing papers by E. Böhni
This network shows the impact of papers produced by E. Böhni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Böhni. The network helps show where E. Böhni may publish in the future.
Co-authors
The 21 scholars most cited alongside E. Böhni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1969 | 35 | |
| 2 | 1965 | 35 | |
| 3 | 1969 | 29 | |
| 4 | 1982 | 25 | |
| 5 | 1964 | 20 | |
| 6 | 1963 | 18 | |
| 7 | Chemotherapeutic activity of the combination of trimethoprim and sulphamethoxazole in infections of mice. | 1969 | 17 |
| 8 | 1956 | 16 | |
| 9 | 1961 | 13 | |
| 10 | [Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo]. | 1969 | 13 |
| 11 | 1955 | 13 | |
| 12 | 1964 | 10 | |
| 13 | 1981 | 8 | |
| 14 | 1976 | 6 | |
| 15 | 1988 | 5 | |
| 16 | 1955 | 5 | |
| 17 | 1965 | 5 | |
| 18 | [Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics]. | 1969 | 4 |
| 19 | [Experimental research with oleandomycin]. | 1956 | 1 |
| 20 | [Experimental studies with oleandomycin and other antibiotics]. | 1956 | 1 |
About E. Böhni
E. Böhni is a scholar working on Molecular Biology, Organic Chemistry, Epidemiology, Pharmacology and Infectious Diseases, having authored 26 papers that have together received 285 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Chemical Synthesis and Analysis (6 papers), Microbial Natural Products and Biosynthesis (5 papers), Tuberculosis Research and Epidemiology (4 papers), Antibiotic Resistance in Bacteria (4 papers), Cancer therapeutics and mechanisms (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Molecular Medicine (50 citations), Pharmacology (85 citations), Microbiology (24 citations), Epidemiology (77 citations) and Organic Chemistry (61 citations). E. Böhni has collaborated with scholars based in Switzerland and United States. Frequent co-authors include W. Lergier, R. O. Studer, K. Vogler, P. Lanz, J. Rieder, László Havas, A. Studer, Rudolf Then, K. Stoeckel and Peter Angehrn. Their work appears in journals such as Helvetica Chimica Acta, Chemotherapy, Cellular and Molecular Life Sciences, European Respiratory Journal and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.